Professor Tim ILLIDGE BSc MB BS PhD FRCP FRCR FRCPath FMedSci Professor of Targeted Therapy and Oncology (University of Manchester) and honorary consultant clinical oncologist (Christie NHS Foundation Trust) Dr Illidge completed his undergraduate degrees BSc in Biochemistry and medicine (MB BS) at Guy’s Hospital, Membership of Royal College of Physicians (1993) and trained in clinical oncology in Southampton (Fellow of Royal College of Radiologists in 1997). His PhD focused on radiotherapy and immunotherapy combinations at University of Southampton and was awarded Young British Cancer researcher of the year (1997) followed by a US Senior Fulbright Fellowship and a United Kingdom Winston Churchill fellowship in 1998 taking him to Stanford University, California. In 1999 he was appointed a CRUK Senior Clinical Research Fellow at University of Southampton and subsequently Professor of Targeted Therapy and Oncology at University of Manchester 2004. He was awarded Fellow of Royal College of Pathologists in 2013 and Fellow of Royal College of Physicians in 2017. He works a clinician scientist and has performed pioneering work in radioimmunotherapy and radiotherapy and immunotherapy combinations. His translational research group have been funded by continuous CRUK programme grants for the last 25 years focusing on proof of principle mechanistic insights to inform early phase clinical trials. His awards have included cancer researcher of the year by University of Manchester in 2012, researcher of the year for the Faculty of Medical and Life sciences in 2013, the Royal College of Radiologists gold medal in 2018, Skeggs medal in 2019, a Senior National Institute of Health Research investigator award in 2019 and Fellow of the Academy of Medical Sciences in 2022.